Article & News

The revised draft National Pharmacy Commission (NPC) Bill, 2026, which aims to set up the National Pharmacy Commission (NPC) and repealing the Pharmacy Act, 1948,

The United States Food and Drug Administration (USFDA) has reached out to Indian pharmaceutical manufacturers through the Indian Drug Manufacturers’ Association (IDMA) for help in

Amid concerns over the illegal entry of unapproved and unlicensed medicines into India, the country’s apex drug regulatory agency has directed all state and Union

India’s USD 30.5-billion pharmaceutical export industry, which supplies medicines to more than 200 countries, could soon see tighter oversight of one of its least regulated

New Delhi: The Central government has ordered an immediate ban on 16 Fixed Dose Combination (FDC) drugs for human use, stating that use is ‘likely

For someone with a dangerous tumor, surgical removal of the cancer may bring immediate relief but leave the person with an uncertain future. Sometimes, remnant

Industry associations have urged the government to make effective use of the substantial unutilised capacity available with domestic Active Pharmaceutical Ingredient (API) manufacturers. This, according

For years, doctors around the world have been locked in a race against a terrifying enemy — bacteria that have learnt how to outsmart medicines.These

India’s ambition to become a global hub for advanced pharmaceuticals will depend on how effectively it balances affordability with a policy environment that supports innovation-led

June 11 (Reuters) – India has given the go-ahead to a regulator for raising prices of platinum-based cancer drugs that have been in ​short supply